OPTIMIZATION OF DOSES OF THIOPURINIC DRUGS (AZATIOPRINE AND MERCAPTOPURINE) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER TREATMENT COMBINED WITH ANTI-TNF alpha (INFLIXIMAB/ADALIMUMAB)

(1) Hospital La Paz,Madrid,Spain

(2) Hospital Puerta de Hierro Dept. de Gastroenterología,Madrid,Spain



This item was part of the IBD I (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019